Figure 1
Norovirus inhibitors in pre-clinical studies. Nitazoxanide (1), 2′-C-methylcytidine (2), valopicitabine (3), PPNDS (4), suramin (5).
Figure 1 | Scientific Reports
Norovirus inhibitors in pre-clinical studies. Nitazoxanide (1), 2′-C-methylcytidine (2), valopicitabine (3), PPNDS (4), suramin (5).
